RBS has identified two clear catalysts for the share price. One is anticipated EU regulatory approval in 1Q 2011 (was end this year previously) and Australian regulatory approval, also in 1Q 2011. The analysts suggest one should start buying the shares prior to these events.
Minor changes made to forecasts have caused the target to slip to $4.04 from $4.06.
Target price is $4.04 Current Price is $2.88 Difference: $1.16 If PXS meets the RBS Australia target it will return approximately 40%
PXS Price at posting:
$2.75 Sentiment: Hold Disclosure: Held
